Doxazosin Induced Angioedema: A Case Report
Article Sidebar
Published:
Dec 1, 2018
Keywords:
Antihypertensive Doxazosin Angioedema
Main Article Content
Abstract
Angioedema, a potentially life-threatening occurrence, is an predominant adverse effect of antihypertensive especially angiotensin converting enzyme inhibitors. However, angioedema due to doxazocin, alfa-1 adrenergic receptor antagonist, was rarely reported in the previous medical literatures. Thus, the aim of this report was to evaluate and report a case of angioedema in a patient taking doxazosin. Healthcare providers should be aware when prescribing doxazosin because there was report of angioedema among patients receiving such agent.
Article Details
Section
รายงานผู้ป่วย (Case Report)
References
1. Kaplan AP, Greaves MW. Angioedema. Journal of the American Academy of Dermatology. 2005;53:373-88.
2. Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P. Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. J Clinical and Experimental Allergy. 2010;40:50-61.
3. Inomata N. Recent advances in drug-induced angioedema. Journal of the British Society for Allergy and Clinical Immunology. 2012;61:545-57.
4. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitorassociated angioedema. Clinical Pharmacology and Therapeutics. 1996;60:8-13.
5. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedem. Incidence, prevention and management. Drug Safety. 1998;18:171-88.
6. Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, et al. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) ALLHAT Research Group. American Journal of Hypertension. 1996;19:342-60.
7. Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Annals of Pharmacotherapy. 2000;4:526-8.
8. LoVerde D, Files DC, Krishnaswamy G. Angioedema. Critical Care Medicine. 2017;45:725-35.
9. Piller LB, Ford CE, Davis BR, Nwachuku C, Black HR, Oparil S, et al. Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of Clinical Hypertension (Greenwich). 2006;8:649-56.
10. Amey G, Waidyasekara P, Kollengode R. Delayed presentation of ACE inhibitor-induced angio-oedema. BMJ case reports. 2013:1-4.
11. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, et al. International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma of Clinical Immunology. 2010;6:24.
2. Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P. Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. J Clinical and Experimental Allergy. 2010;40:50-61.
3. Inomata N. Recent advances in drug-induced angioedema. Journal of the British Society for Allergy and Clinical Immunology. 2012;61:545-57.
4. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitorassociated angioedema. Clinical Pharmacology and Therapeutics. 1996;60:8-13.
5. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedem. Incidence, prevention and management. Drug Safety. 1998;18:171-88.
6. Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, et al. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) ALLHAT Research Group. American Journal of Hypertension. 1996;19:342-60.
7. Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Annals of Pharmacotherapy. 2000;4:526-8.
8. LoVerde D, Files DC, Krishnaswamy G. Angioedema. Critical Care Medicine. 2017;45:725-35.
9. Piller LB, Ford CE, Davis BR, Nwachuku C, Black HR, Oparil S, et al. Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Journal of Clinical Hypertension (Greenwich). 2006;8:649-56.
10. Amey G, Waidyasekara P, Kollengode R. Delayed presentation of ACE inhibitor-induced angio-oedema. BMJ case reports. 2013:1-4.
11. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, et al. International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma of Clinical Immunology. 2010;6:24.